24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
VBL Therapeutics
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:10
“In 10 years there will be a very big problem here if Israel doesn’t go all-in on AI”
12:52
Prof. Ran Balicer: "We prevent diseases using AI"
12:17
LeumiTech CEO: "This year we reached a record number of serial Israeli entrepreneurs"
10:52
The $660 billion question: When does AI pay back?
More stories
Buzz
Most popular
Daily
Weekly
1
Chinese billionaire poised to acquire Netafim in $1.4 billion deal
2
Wiz CEO Assaf Rappaport acquires $13 million estate after years in rented apartment
3
IBM invests in Israeli startup Anima to bring “vibe coding” into the enterprise
4
Mapping Israel’s AI infrastructure opportunity
5
Israel signs $130 million deal with Elbit to outfit next-generation helicopters
More news
VBL Therapeutics
2 stories about VBL Therapeutics
VBL Therapeutics Aims to Raise $18.75 Million in Public Offering
20.11.17
|
Lilach Baumer
The cancer treatment company announced an offering of 2.5 million shares last week
Japanese NanoCarrier Partners with Cancer Treatment Company VBL Therapeutics
07.11.17
|
Dror Reich
The companies signed an exclusive licensing agreement in Japan for VBL's anti-cancer drug
